A novel three-way rearrangement involving ETV6 (12p13) and ABL1 (9q34) with an unknown partner on 3p25 resulting in a possible ETV6-ABL1 fusion in a patient with acute myeloid leukemia: a case report and a review of the literature
Tóm tắt
Acute myeloid leukemia (AML) is commonly characterized by several chromosomal abnormalities resulting in the formation of chimeric genes that play various roles in leukemogenesis. Translocations resulting in the ETV6-ABL1 fusion gene are rare in AML and other hematologic malignancies with only thirty-two previously reported cases in the literature, five of which were AML. Herein, we report the case of a 73-year-old male with acute myeloid leukemia arising from MDS, negative for PDGFRA and PDGFRB, positive for bone marrow eosinophilia, rash, and marked fluid retention, which improved dramatically with imatinib therapy. Conventional cytogenetics revealed a t(3;9)(p25;q34), t(5;18)(q13;p11.2), and additional material of unknown origin at 12p11.2 in 2 out of 10 metaphases analyzed. Interphase FISH studies showed evidence of ETV6 (12p13) and ABL1 (9q34) rearrangements in 41.3 % and 5.7 % of the cells respectively. FISH studies on previously G-banded metaphases showed colocalization of ABL1 and ETV6 signals to the short arm of chromosome 3 at 3p25 suggesting a possible ETV6-ABL1 fusion. Subtelomeric metaphase FISH studies also showed the presence of a subtelomere 3p signal on the long arm of the derivative 9, and no subtelomere 3p signal on the derivative chromosome 12. These findings suggest a complex rearrangement involving an insertion of ETV6 into 3p25 followed by a reciprocal translocation involving 3p25 and 9q34, resulting in a possible ETV6-ABL1 fusion. This case highlights the importance of FISH to characterize complex rearrangements in myeloid malignancies, particularly those resulting in clinically significant chimeric genes.
Tài liệu tham khảo
Gancheva K, Virchis A, Howard-Reeves J, Cross NC, Brazma D, Grace C, Kotzampaltiris P, Partheniou F, Nacheva E. Myeloproliferative Neoplasm with ETV6-ABL1 Fusion: A Case Report and Literature Review. Mol Cytogenet. 2013;6(1):39.
Andreasson P, Johansson B, Carlsson M, Jarlsfelt I, Fioretos T, Mitelman F, Höglund M. BCR/ABL-negative chronic myeloid leukemia with ETV6/ABL fusion. Genes Chromosomes Cancer. 1997;20(3):299–304.
Golub TR, Goga A, Barker GF, Afar DE, Mclaughlin J, Bohlander SK, Rowley JD, Witte ON, Gilliland DG. Oligomerization of the ABL Tyrosine Kinase by the Ets Protein TEL in Human Leukemia. Mol Cell Biol. 1996;16(8):4107–116.
La Starza R, Trubia M, Testoni N, Ottaviani E, Belloni E, Crescenzi B, Martelli M, Flandrin G, Pelicci PG, Mecucci C. Clonal eosinophils are a morphologic hallmark of ETV6/ABL1 positive acute myeloid leukemia. Haematologica. 2002;87(8):789–94.
Pelly T, Harvey Y, Brookwell R, Wordsworth H, Keng TB. A case report of an ETV6-ABL1 [t(6;9;12)] positive myeloproliferative neoplasm. Pathology. 2012;45(1):S95.
Tirado CA, Sebastian S, Moore JO, Gong JZ, Goodman BK. Molecular and Cytogenetic Characterization of a Novel Rearrangement Involving Chromosomes 9, 12, and 17 Resulting in ETV6 (TEL) and ABL Fusion. Cancer Genet Cytogenet. 2005;157(1):74–7.
Zuna J, Zaliova M, Muzikova K, Meyer C, Lizcova L, Zemanova Z, Brezinova J, Votava F, Marschalek R, Stary J, Trka J. Acute leukemias with ETV6/ABL1 (TEL/ABL) fusion: poor prognosis and prenatal origin. Genes Chromosomes Cancer. 2010;49(10):873–84. doi:10.1002/gcc.20796.
De Braekeleer E, Douet-Guilbert N, Rowe D, Bown N, Morel F, Berthou C, Férec C, De Braekeleer M. ABL1 fusion genes in hematological malignancies: a review. Eur J Haematol. 2011;86(5):361–71. doi:10.1111/j.1600-0609.2011.01586.x. Epub 2011 Mar 23.
Shaffer LG, McGowan-Jordan J, Schmid M. An International System for Human Cytogenetic Nomenclature. Basel: International Standing Committee on Human Cytogenetic Nomenclature, Karger; 2013.
Ishikawa M, Yagasaki F, Okamura D, Maeda T, Sugahara Y, Jinnai I, Bessho M. A novel gene, ANKRD28 on 3p25, is fused with NUP98 on 11p15 in a cryptic 3-way translocation of t(3;5;11)(p25;q35;p15) in an adult patient with myelodysplastic syndrome/acute myelogenous leukemia. Int J Hematol. 2007;86(3):238–45.
Johansson B, Billström R, Kristoffersson U, Åkerman M, Garwicz S, Ahlgren T, Malm C, Mitelman F. Deletion of Chromosome Arm 3p in Hematologic Malignancies. Leukemia. 1997;11(8):1207–213.
Song JS, Shin SY, Lee ST, Kim HJ, Kim SH. A Cryptic ETV6/ABL1 Rearrangement Represents a Unique Fluorescence In Situ Hybridization Signal Pattern in a Patient with B Acute Lymphoblastic Leukemia. Ann Lab Med. 2014;34(6):475.
Park J, Kim M, Lim J, Kim Y, Han K, Kim JS, Lee S, Kim HJ, Min WS. Variant of ETV6/ABL1 Gene Is Associated with Leukemia Phenotype. Acta Haematologica Acta Haematol. 2013;129(2):78–82.
O'Brien SG, Vieira SA, Connors S, Bown N, Chang J, Capdeville R, Melo JV. Transient response to imatinib mesylate (STI571) in a patient with the ETV6-ABL t(9;12) translocation. Blood. 2002;99(9):3465–7.
Million RP, Aster J, Gilliland DG, Van Etten RA. The Tel-Abl (ETV6-Abl) tyrosine kinase, product of complex (9;12) translocations in human leukemia, induces distinct myeloproliferative disease in mice. Blood. 2002;99(12):4568–77.
Voss J, Posern G, Hannemann JR, Wiedemann LM, Turhan AG, Poirel H, Bernard OA, Adermann K, Kardinal C, Feller SM. The Leukaemic Oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) Have Altered Substrate Preferences and Activate Similar Intracellular Signalling Pathways. Oncogene. 2000;19(13):1684–690.
Birge RB, Kalodimos C, Inagaki F, Tanaka S. Crk and CrkL Adaptor Proteins: Networks for Physiological and Pathological Signaling. Cell Commun Signal. 2009;7(1):13.
Kawamata N, Dashti A, Lu D, Miller B, Koeffler HP, Schreck R, Moore S, Ogawa S. Chronic Phase of ETV6-ABL1 Positive CML Responds to Imatinib. Genes Chromosomes Cancer. 2008;47(10):919–21.
Greuber EK, Smith-Pearson P, Wang J, Pendergast AM. Role of ABL family kinases in cancer: from leukaemia to solid tumours. Nat Rev Cancer. 2013;13(8):559–71. doi:10.1038/nrc3563. Epub 2013 Jul 11.
Barbouti A, Ahlgren T, Johansson B, Höglund M, Lassen C, Turesson I, Mitelman F, Fioretos T. Clinical and Genetic Studies of ETV6/ABL1-positive Chronic Myeloid Leukaemia in Blast Crisis Treated with Imatinib Mesylate. Br J Haematol. 2003;122(1):85–93.
Kelly JC, Shahbazi N, Scheerle J, Jahn J, Suchen S, Christacos NC, Mowrey PN, Witt MH, Hostetter A, Meloni-Ehrig AM. Insertion (12;9)(p13;q34q34): A Cryptic Rearrangement Involving ABL1/ETV6 Fusion in a Patient with Philadelphia-negative Chronic Myeloid Leukemia. Cancer Genet Cytogenet. 2009;192(1):36–9.
Perna F, Abdel-Wahab O, Levine RL, Jhanwar SC, Imada K, Nimer SD. ETV6-ABL1-positive "chronic Myeloid Leukemia": Clinical and Molecular Response to Tyrosine Kinase Inhibition. Haematologica. 2010;96(2):342–43.
Papadopoulos P, Ridge SA, Boucher CA, Stocking C, Wiedemann LM. The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res. 1995;55(1):34–8.
Van Limbergen H, Beverloo HB, van Drunen E, Janssens A, Hählen K, Poppe B, Van Roy N, Marynen P, De Paepe A, Slater R, Speleman F. Molecular cytogenetic and clinical findings in ETV6/ABL1-positive leukemia. Genes Chromosomes Cancer. 2001;30(3):274–82.
Baeumler J, Szuhai K, Falkenburg JH, van Schie ML, Ottmann OG, Nijmeijer BA. Establishment and cytogenetic characterization of a human acute lymphoblastic leukemia cell line (ALL-VG) with ETV6/ABL1 rearrangement. Cancer Genet Cytogenet. 2008;185(1):37–42. doi:10.1016/j.cancergencyto.2008.05.001.
Malone A, Langabeer S, O'Marcaigh A, Storey L, Bacon CL, Smith OP. A doctor(s) dilemma: ETV6-ABL1 positive acute lymphoblastic leukaemia. Br J Haematol. 2010;151(1):101–2. doi:10.1111/j.1365-2141.2010.08323.x. Epub 2010 Jul 7.
Zhou MH, Gao L, Jing Y, Xu YY, Ding Y, Wang N, Wang W, Li MY, Han XP, Sun JZ, Wang LL, Yu L. Detection of ETV6 gene rearrangements in adult acute lymphoblastic leukemia. Ann Hematol. 2012;91(8):1235–43. doi:10.1007/s00277-012-1431-4. Epub 2012 Feb 29.
Brunel V, Sainty D, Carbuccia N, Mazzicconacci M, Fernandez F, Simonetti J, Gabert J, Debreuil P, Lafage-Pochitaloff M, Birg F. A TEL/ABL fusion gene on chromosome 12p13 in a case of Ph-. BCR- atypical CML. Leukemia. 1996;10:2003.
Keung YK, Beaty M, Steward W, Jackle B, Pettnati M. Chronic myelocytic leukemia with eosinophilia, t(9;12)(q34;p13), and ETV6-ABL1 gene rearrangement: case report and review of the literature. Cancer Genet Cytogenet. 2002;138(2):139–42.
Lin H, Guo JQ, Andreeff M, Arlinghaus RB. Detection of dual TEL-ABL transcripts and a Tel-Abl protein containing phosphotyrosine in a chronic myeloid leukemia patient. Leukemia. 2002;16(2):294–7.
Meyer-Monard S, Mühlematter D, Streit A, Chase AJ, Gratwohl A, Cross NC, Jotterand M, Tichelli A. Broad molecular screening of an unclassifiable myeloproliferative disorder reveals an unexpected ETV6/ABL1 fusion transcript. Leukemia. 2005;19(6):1096–9.
Mozziconacci MJ, Sainty D, Chabannon C. A fifteen-year cytogenetic remission following interferon treatment in a patient with an indolent ETV6-ABL positive myeloproliferative syndrome. Am J Hematol. 2007;82(7):688–9.
Nand R, Bryke C, Kroft SH, Divgi A, Bredeson C, Atallah E. Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors. Leuk Res. 2009;33(8):1144–6. doi:10.1016/j.leukres.2009.03.011. Epub 2009 Apr 25.
Yamamoto K, Yakushijin K, Nakamachi Y, Miyata Y, Sanada Y, Tanaka Y, Okamura A, Kawano S, Hayashi Y, Matsuoka H, Minami H. Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2). Ann Hematol. 2014;93(8):1435–8. doi:10.1007/s00277-013-1975-y. Epub 2013 Dec 8.